Whan In Pharm Co.,Ltd. (KRX:016580)
South Korea · Delayed Price · Currency is KRW 10,620
+80 (0.76%)
At close: Jan 9, 2026
Whan In Pharm Market Cap
Whan In Pharm has a market cap or net worth of 162.14 billion as of January 9, 2026. Its market cap has decreased by -8.21% in one year.
Market Cap
162.14B
Enterprise Value
103.21B
Revenue
256.32B
Ranking
n/a
PE Ratio
10.85
Stock Price
10,620.00
Market Cap Chart
Since June 24, 1997, Whan In Pharm's market cap has increased from 51.22B to 162.14B, an increase of 216.55%. That is a compound annual growth rate of 4.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 162.14B | -6.18% |
| Dec 30, 2025 | 172.82B | -4.15% |
| Dec 30, 2024 | 180.30B | -21.48% |
| Dec 28, 2023 | 229.62B | -14.55% |
| Dec 29, 2022 | 268.70B | -1.12% |
| Dec 30, 2021 | 271.75B | 6.59% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 81.80T |
| Celltrion | 46.17T |
| ALTEOGEN | 25.19T |
| ABL Bio | 11.60T |
| SK Biopharmaceuticals | 9.76T |
| Yuhan | 8.45T |
| HLB Co., Ltd. | 7.19T |
| LigaChem Biosciences | 6.51T |